Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Transfusion of CMV Seronegative T-Deplete Allogeneic Stem Cell Transplant Recipients with CMV Unselected Blood Products Confers a Zero Risk of CMV Transmission in the Era of Universal Leucodepletion: A UK Single-Centre Experience

Suzanne Hall, MB BCh, FRCPath, Sandeep Nagra, MBChB, Husam Osman, MB BCh, Mark Cook, PhD FRCPath, Charles F. Craddock, BM, MRCP, MRCPath, Sridhar Chaganti, MD PhD

Blood (2014) 124 (21): 2894.

https://doi.org/10.1182/blood.V124.21.2894.2894

Published: 2014

Journal Articles

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

David Burns, Shabeeha Rana, Andrew Howman, Sandeep Nagra, Janice Ward, Husam Osman, Yusri Taha, Jenny Byrne, Emma Das-Gupta, Manoj Raghavan, Ram Malladi, Mark Cook, Prem Mahendra, Nigel H. Russell, MD, Charles Craddock, Christopher Fox, Sridhar Chaganti

Blood (2012) 120 (21): 460.

https://doi.org/10.1182/blood.V120.21.460.460

Published: 2012

Journal Articles

Pre-Emptive Rituximab for Epstein-Barr Virus Reactivation Post Stem Cell Transplant: High CRP and PTLD At Initiation of Treatment Confer Inferior Outcome

David Burns, Sandeep Nagra, Husam Osman, Ram Malladi, Manoj Raghavan, Fiona Clark, Mark Cook, Prem Mahendra, Charles Craddock, Sridhar Chaganti

Blood (2011) 118 (21): 3007.

https://doi.org/10.1182/blood.V118.21.3007.3007

Published: 2011

Journal Articles

Expansion of CD38 + Activated B Cells in Circulation as a Manifestation of Early Onset EBV Associated Post-Transplant Lymphoproliferative Disease.

Sridhar Chaganti, Sandeep Nagra, Mark Cook, Premini Mahendra, Charles Craddock, Husam Osman, Andrew Hislop, Sylvie Freeman, Fiona Clark

Blood (2007) 110 (11): 5013.

https://doi.org/10.1182/blood.V110.11.5013.5013

Published: 2007

Journal Articles

Donor KIR Genotype Does Not Affect VZV Reactivation after Allogeneic Haematopoietic Stem Cell Transplantation.

Sujaatha Narayanan, MBBS, Sandeep Nagra, MBChB, Premini Mahendra, MD, FRCPath, Fiona J. Clark, MRCPath, Charles F. Craddock, PhD, FRCPath, Husam Osman, PhD, MRCPath, David C. Briggs, PhD, Paul A. Moss, PhD, FRCPath, Mark A. Cook, MRCPath

Blood (2005) 106 (11): 3236.

https://doi.org/10.1182/blood.V106.11.3236.3236

Published: 2005

Journal Articles

Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

Suparno Chakrabarti, Vivien Mautner, Husam Osman, Kathryn E. Collingham, Chris D. Fegan, Paul E. Klapper, Paul A. H. Moss, Donald W. Milligan

Blood (2002) 100 (5): 1619–1627.

https://doi.org/10.1182/blood-2002-02-0377

Published: 2002

Journal Articles

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra, Panagiotis D. Kottaridis, Karl Peggs, Peter O'Gorman, Ronjon Chakraverty, Timothy Marshall, Husam Osman, Premini Mahendra, Charles Craddock, Herman Waldmann, Geoff Hale, Christopher D. Fegan, Kwee Yong, Anthony H. Goldstone, David C. Linch, Donald W. Milligan

Blood (2002) 99 (12): 4357–4363.

https://doi.org/10.1182/blood.V99.12.4357

Published: 2002

NARROW

Transfusion of CMV Seronegative T-Deplete Allogeneic Stem Cell Transplant Recipients with CMV Unselected Blood Products Confers a Zero Risk of CMV Transmission in the Era of Universal Leucodepletion: A UK Single-Centre Experience

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

Pre-Emptive Rituximab for Epstein-Barr Virus Reactivation Post Stem Cell Transplant: High CRP and PTLD At Initiation of Treatment Confer Inferior Outcome

Expansion of CD38 + Activated B Cells in Circulation as a Manifestation of Early Onset EBV Associated Post-Transplant Lymphoproliferative Disease.

Donor KIR Genotype Does Not Affect VZV Reactivation after Allogeneic Haematopoietic Stem Cell Transplantation.

Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Email alerts

ASH Publications

American Society of Hematology

Transfusion of CMV Seronegative T-Deplete Allogeneic Stem Cell Transplant Recipients with CMV Unselected Blood Products Confers a Zero Risk of CMV Transmission in the Era of Universal Leucodepletion: A UK Single-Centre Experience

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

Pre-Emptive Rituximab for Epstein-Barr Virus Reactivation Post Stem Cell Transplant: High CRP and PTLD At Initiation of Treatment Confer Inferior Outcome

Expansion of CD38 + Activated B Cells in Circulation as a Manifestation of Early Onset EBV Associated Post-Transplant Lymphoproliferative Disease.

Donor KIR Genotype Does Not Affect VZV Reactivation after Allogeneic Haematopoietic Stem Cell Transplantation.

Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only